Marlies Y Bongers Selected Research

Levonorgestrel (Plan B)

1/2024	A 52 mg levonorgestrel-releasing intrauterine system versus bipolar radiofrequency non-resectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multi-center randomized controlled trial.
11/2022	Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?
1/2022	Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
11/2021	Effect of lower VWF and FXI levels on levonorgestrel IUS and endometrial ablation treatment success in heavy menstrual bleeding: An exploratory study.
10/2021	The combined use of endometrial ablation or resection and levonorgestrel-releasing intrauterine system in women with heavy menstrual bleeding: A systematic review.
1/2021	Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
1/2021	Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
9/2018	Women's preferences for the levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding.
8/2013	Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial.
7/2004	Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marlies Y Bongers Research Topics

Disease

18	Menorrhagia 01/2024 - 05/2003
9	Hemorrhage 04/2024 - 03/2004
9	Prolapse 11/2023 - 01/2009
9	Endometrial Neoplasms (Endometrial Cancer) 12/2022 - 08/2010
8	Pelvic Organ Prolapse 12/2023 - 01/2009
5	Metrorrhagia (Spotting) 10/2010 - 03/2004
4	Leiomyoma (Uterine Fibroids) 04/2024 - 01/2020
4	Pain (Aches) 01/2022 - 11/2006
4	Dysmenorrhea (Menstrual Pain) 01/2021 - 03/2013
3	Uterine Prolapse (Vaginal Prolapse) 08/2023 - 12/2022
3	Spontaneous Abortion (Miscarriage) 03/2018 - 01/2017
2	Urinary Retention 12/2022 - 07/2020
2	Pelvic Pain 11/2022 - 01/2022
2	Uterine Hemorrhage (Uterine Bleeding) 01/2022 - 12/2015
2	Endometriosis 07/2020 - 05/2018
2	Myoma 12/2019 - 03/2013
2	Urinary Incontinence 01/2018 - 07/2007
2	Amenorrhea 01/2016 - 03/2005
1	Postoperative Pain 08/2023
1	Intraoperative Complications 08/2023
1	Iron-Refractory Iron Deficiency Anemia 02/2022
1	Inflammation (Inflammations) 02/2022
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 02/2022
1	Urinary Tract Infections (Urinary Tract Infection) 07/2020
1	Abdominal Pain (Pain, Abdominal) 07/2018
1	Neoplasms (Cancer) 01/2018
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2018
1	Stress Urinary Incontinence 05/2013
1	Endometrial Hyperplasia 11/2011
1	Uterine Retroversion 05/2003

Drug/Important Bio-Agent (IBA)

11	Levonorgestrel (Plan B)FDA LinkGeneric 01/2024 - 03/2004
2	AnticoagulantsIBA 01/2021 - 12/2015
2	Estrogens (Estrogen)FDA Link 02/2020 - 01/2018
2	Misoprostol (Cytotec)FDA LinkGeneric 03/2018 - 04/2017
2	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2017
1	SuspensionsIBA 12/2023
1	Propofol (Diprivan)FDA LinkGeneric 08/2023
1	zaleplon (Sonata)FDA LinkGeneric 11/2022
1	HepcidinsIBA 02/2022
1	matriptase 2IBA 02/2022
1	IronIBA 02/2022
1	Transferrin (beta 2 Transferrin)IBA 02/2022
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Hormones (Hormone)IBA 09/2018
1	Estrone FDA Link 01/2018
1	EnzymesIBA 01/2018
1	Cyclin AIBA 01/2018
1	auto-cross-linked polysaccharideIBA 01/2017
1	Pain-FreeIBA 10/2009
1	TutoplastIBA 01/2009
1	Polypropylenes (Polypropylene)IBA 01/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2006
1	Analgesics (Analgesic Drugs)IBA 11/2006
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 03/2004
1	Tranexamic Acid (AMCA)FDA Link 03/2004

Therapy/Procedure

21	Endometrial Ablation Techniques 04/2024 - 03/2004
19	Hysterectomy 04/2024 - 05/2003
8	Therapeutics 04/2024 - 05/2003
6	Laparotomy 01/2022 - 08/2010
4	Uterine Myomectomy 04/2024 - 01/2020
4	Radiofrequency Ablation 11/2022 - 10/2004
4	Operative Surgical Procedures 01/2019 - 04/2011
3	Vaginal Hysterectomy 11/2023 - 12/2017
3	Aftercare (After-Treatment) 11/2022 - 12/2011
3	Length of Stay 01/2018 - 08/2010
2	Indwelling Catheters (Indwelling Catheter) 12/2022 - 07/2020
2	Intrauterine Devices (Intrauterine Device) 11/2022 - 07/2004
2	Cesarean Section (Caesarean Section) 01/2021 - 03/2013
2	Tubal Sterilization (Tubal Ligation) 12/2019 - 05/2018
2	Pessaries 01/2019 - 01/2018
2	Contraception (Birth Control) 09/2018 - 03/2004
2	Curettage 03/2018 - 04/2017
2	Obstetrical Anesthesia 01/2016 - 10/2009
2	Salpingo-oophorectomy 11/2011 - 08/2010
2	Ablation Techniques 10/2010 - 10/2004
1	Sutures (Suture) 12/2023
1	Patient Admission (Patient Admissions) 08/2023
1	Urinary Catheters 12/2022
1	Contraceptive Effectiveness 11/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Contraindications 01/2022
1	Catheters 07/2020
1	Bariatric Surgery 07/2018
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2018
1	Laparoscopic Cholecystectomy 01/2018
1	Dilatation and Curettage 02/2016
1	Suburethral Slings (Tension-Free Vaginal Tape) 11/2006